Business Environment

Pharmaceutical Market: Rapid growth Chinese Market and Steady Japanese Market

The World’s Pharmaceutical Market sales total is 1,439.5 billion US dollars (in 2021).
The biggest market is the United States, the second is China, and third place is Japan.

We focus on Japan, China as well as other Asian markets which are in the top level of pharmaceutical market sizes, to contribute to the medical and healthcare in these Asian countries.

Growing Medical Needs in the “Oncology Field”

Our business position in the pharmaceutical supply chain

Solasia’s Revenue

1. Revenue: Products sales
2. Revenue: “Signing fee^*” of Out-licensing
3. Revenue: “Milestones of development^*” status
4. Revenue: “Commercial milestones^*” at achieved certain commercial sales target
5. Revenue: “Royalty^*” from the contract deal

• Signing fee：Payment signing fee of In-licensing
• Development Milestone：Payment milestones of development status
• Commercial milestones：Payment commercial milestones at achieved certain commercial sales target
• Royalty：Payment royalty due to the contract deal from licensee

What is the R&D for Pharmaceuticals?

In Japan, it generally takes a long period such as ten years or more and cost it a large amount of R&D expenses more than tens of billions of Japanese yen to develop one new drug. And even with that much time and cost, the success rate of a compound being launched as a new drug is only about 1 / 30,000 (0.003%).

Solasia’s Products / Pipeline

Proceeding with a wide range of development for both: Anti-cancer drugs and drugs aimed at controlling side effects caused by cancer treatment.

Since our founding, we have worked on five development products, three of which have already been successfully developed and delivered to patients. We will continue to develop innovative medicines/medical devices so that we can contribute to patients’ treatment and enhanced quality of life.